Appointment booking for Dr. Ravindra Mailapur, MD is currently not available.Dr. Ravindra Mailapur, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Ravindra Mailapur, MD (he/him) is a Surgeon in Huntsville, AL with over 18 years of experience. What is your opinion of Dr. Ravindra Mailapur, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ravindra Mailapur, MD has received over $11,423 which includes payments from the following companies:
$1,538.38 from Covidien LP
$1,042.65 from Ethicon US, LLC
$964.91 from LifeCell Corporation
$953.28 from Intuitive Surgical, Inc.
$891.90 from APOLLO ENDOSURGERY INC
$825.35 from Novo Nordisk Inc
$752.32 from DePuy Orthopaedics Inc.
$501.50 from Stryker Corporation
$360.03 from Allergan Inc.
$329.83 from The Medicines Company
$316.28 from KCI USA, Inc
$306.88 from Par Pharmaceutical, Inc.
$298.14 from Davol Inc.
$297.05 from Baxter Healthcare
$278.40 from Mallinckrodt LLC
$203.00 from W. L. Gore & Associates, Inc.
$178.67 from Endo Pharmaceuticals Inc.
$148.26 from TELA Bio, Inc.
$139.81 from Pacira Pharmaceuticals Incorporated
$125.20 from LILLY USA, LLC
Payments received by Dr. Ravindra Mailapur, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!